Dos Santos M, Fintelman-Rodrigues N, da Silva A, Silva R, Seixas V, Batista-da-Silva A
Front Microbiol. 2025; 16:1483895.
PMID: 40012790
PMC: 11861056.
DOI: 10.3389/fmicb.2025.1483895.
Shah D, Bhide S, Deshmukh R, Smith J, Kaiplyawar S, Puri V
Front Tuberc. 2024; 2.
PMID: 39421397
PMC: 11485165.
DOI: 10.3389/ftubr.2024.1454277.
Malani A, Aiyar J, Sant A, Kamran N, Mohanan M, Taneja S
Sci Rep. 2024; 14(1):5758.
PMID: 38459035
PMC: 10923858.
DOI: 10.1038/s41598-024-54922-z.
Selvavinayagam T, Somasundaram A, Maria Selvam J, Sampath P, Vijayalakshmi V, Kumar C
Sci Rep. 2024; 14(1):2091.
PMID: 38267448
PMC: 10808562.
DOI: 10.1038/s41598-023-50338-3.
Charles H, Fatima C, Lucio V, Maria K, Johar C, Kevin P
Glob Epidemiol. 2024; 7:100131.
PMID: 38188037
PMC: 10767270.
DOI: 10.1016/j.gloepi.2023.100131.
Integrating health belief model and theory of planned behavior to assess COVID-19 vaccine acceptance among urban slum people in Bangladesh.
Patwary M, Disha A, Hasan M, Bardhan M, Hasan M, Tuhi F
PLoS One. 2023; 18(12):e0290412.
PMID: 38117841
PMC: 10732453.
DOI: 10.1371/journal.pone.0290412.
Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study.
Majiya H, Aliyu-Paiko M, Balogu V, Musa D, Salihu I, Kawu A
JMIRx Med. 2023; 4:e29587.
PMID: 37855218
PMC: 10595504.
DOI: 10.2196/29587.
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.
Chansaenroj J, Suntronwong N, Kanokudom S, Assawakosri S, Vichaiwattana P, Klinfueng S
Sci Rep. 2023; 13(1):15595.
PMID: 37730917
PMC: 10511501.
DOI: 10.1038/s41598-023-42754-2.
Differential practice and associated factors of COVID-19 personal preventive measures among the slum and estate communities of Uganda: A community-based cross-sectional survey.
Kawuki J, Nambooze J, Chan P, Chen S, Liang X, Mo P
J Glob Health. 2023; 13:06039.
PMID: 37712388
PMC: 10502765.
DOI: 10.7189/jogh.13.06039.
Seroprevalence of IgG and IgM Antibodies against SARS-CoV-2 Infection in Inhabitants of Itanagar Capital Region, Arunachal Pradesh, India.
Nobin H, Kothapalli J, Jini M, Chauhan S, Tato Y, Munikumar M
Maedica (Bucur). 2023; 18(1):88-95.
PMID: 37266471
PMC: 10231152.
DOI: 10.26574/maedica.2023.18.1.88.
COVID-19 Vaccine Acceptance, Attitude and Perception among Slum and Underserved Communities: A Systematic Review and Meta-Analysis.
Kawuki J, Chen S, Fang Y, Liang X, Chan P, Wang Z
Vaccines (Basel). 2023; 11(5).
PMID: 37242990
PMC: 10222524.
DOI: 10.3390/vaccines11050886.
Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
Agarwal D, Patil R, Roy S, Kaur H, Mehandale S, Bavdekar A
J Glob Health. 2023; 13:06011.
PMID: 37079274
PMC: 10117619.
DOI: 10.7189/jogh.13.06011.
Relative deprivation, inequality and the Covid-19 pandemic.
Chakrabarty D, Bhatia B, Jayasinghe M, Low D
Soc Sci Med. 2023; 324:115858.
PMID: 36989836
PMC: 10027304.
DOI: 10.1016/j.socscimed.2023.115858.
Differential COVID-19 Vaccination Uptake and Associated Factors among the Slum and Estate Communities in Uganda: A Cross-Sectional Population-Based Survey.
Kawuki J, Nambooze J, Chan P, Chen S, Liang X, Mo P
Vaccines (Basel). 2023; 11(2).
PMID: 36851317
PMC: 9965522.
DOI: 10.3390/vaccines11020440.
Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
Irenge L, Bulakali H, Akonkwa A, Ambroise J, Gala J
Epidemiol Infect. 2023; 151:e24.
PMID: 36775822
PMC: 9947032.
DOI: 10.1017/S0950268823000158.
The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.
Haddad-Boubaker S, Arbi M, Souiai O, Chouikha A, Fares W, Edington K
Front Public Health. 2023; 10:990832.
PMID: 36684874
PMC: 9846204.
DOI: 10.3389/fpubh.2022.990832.
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
Emmenegger M, De Cecco E, Lamparter D, Jacquat R, Riou J, Menges D
iScience. 2023; 26(2):105928.
PMID: 36619367
PMC: 9811913.
DOI: 10.1016/j.isci.2023.105928.
Seroprevalence of SARS-CoV-2 antibodies among Forcibly Displaced Myanmar Nationals in Cox's Bazar, Bangladesh 2020: a population-based cross-sectional study.
Rahman M, Khan S, Alamgir A, Kennedy D, Hakim F, Evers E
BMJ Open. 2022; 12(11):e066653.
PMID: 36410810
PMC: 9679871.
DOI: 10.1136/bmjopen-2022-066653.
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone K, Khan S, Qurieshi M, Majid S, Pandit M, Haq I
Front Public Health. 2022; 10:967447.
PMID: 36276377
PMC: 9582950.
DOI: 10.3389/fpubh.2022.967447.
SARS-CoV-2 seropositivity among non-medical frontline workers in Pune, Maharashtra, India.
Deoshatwar A, Gokhale M, Sapkal G, Viswanathan R, Potdar V, Tilekar B
Indian J Med Res. 2022; 155(5&6):578-581.
PMID: 36124498
PMC: 9807206.
DOI: 10.4103/ijmr.ijmr_2484_21.
